Last updated 2026-07-20
Total raised
—
Stage
Pre-Funding
Founded
2018
Headcount
5
HQ
Haifa, Israel
Sector
Health Tech & Life Sciences
About
Rise Nano Optics is a health technology company specializing in advanced nanotechnology lens solutions designed to selectively filter high-energy visible light wavelengths. Its patented SpectraGuard™ technology integrates nanomaterial innovation, ophthalmic research, and scalable optical engineering to serve both clinical and consumer eyewear markets globally. The company's purpose is to reduce the risk of cataracts and retinopathy in diabetes patients, using eyewear that filters harmful sunlight wavelengths. Rise Nano Optics develops unique nanotechnology eyewear solutions, and its innovative filtering system blocks harmful sunlight wavelengths and reduces the risk of diabetes-related eye diseases, such as cataracts and retinopathy.
Headcount over time
From 2 (2020-10) to 3 (2025-12) · +1 (+50%) · 4 points · source: Finder history + radar grounding
Q&A
- What is Rise Nano Optics' primary focus?
- Rise Nano Optics develops nanotechnology eyewear solutions designed to filter harmful sunlight wavelengths and reduce the risk of diabetes-related eye diseases such as cataracts and retinopathy.
- When was Rise Nano Optics founded?
- Rise Nano Optics was founded in July 2017.
- Where is Rise Nano Optics headquartered?
- Rise Nano Optics is headquartered in Haifa, Israel.
- What is the current employee count for Rise Nano Optics?
- Rise Nano Optics has 1-10 employees.
- Who is the Founder and CEO of Rise Nano Optics?
- Inas Said is the Founder and CEO of Rise Nano Optics.
- What is the current funding stage of Rise Nano Optics?
- Rise Nano Optics is currently in the Pre-Funding stage.
- Does Rise Nano Optics hold any patents?
- Yes, Rise Nano Optics holds one patent for its technology.
- What is the main benefit of Rise Nano Optics' patented technology?
- Rise Nano Optics' patented, second-generation solution uses advanced nanotechnology to effectively block harmful UV, blue light, and diabetes-spectrum wavelengths, reducing light intensity with transparent lenses, and preventing the development and progress of diabetes-related cataracts and retinopathy.
Team · 1
Inas Said
Founder · CEO & Founder
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Target customers
Industrial ManufacturingDiscrete IndustriesSemiconductors & ElectronicsAutomotiveHealthcare & Life SciencesLife Sciences
Business model
B2B
Highlights
1 Patents
Tags
nanotechnologydiabetesdermatologynon-invasiveeye-diseases
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | risenanooptics.com |
|---|---|
| linkedin.com/company/42296789 |
Identifiers & details
| Legal name | Rise Nano Optics Ltd. |
|---|---|
| Founded | 2018 |
| Employees (exact) | 5 |
Radar intelligence
Patents
| EPO | 2 |
|---|
Web history (Wayback)
| Domain | risenanooptics.com |
|---|
Certificate / subdomain footprint
| Subdomains | 2 |
|---|
Israeli Companies Registrar (רשם החברות / ICA)
| Registrar # (ח.פ.) | 515695112 |
|---|---|
| Status | פעילה |
| Corp type | ישראלית חברה פרטית |
| Incorporated | 2017-07-24 |
| Purpose | לעסוק בכל עיסוק חוקי |
| Liability | מוגבלת |
| In violation (unfiled) | no |
| Last annual report | 2024 |
| Active charges / liens | 0 |
| Registry events | 8 — shares_capital (2), people (1), other (1), charge (4) |
| Registered address | נועום אל-ג'ליל 5 שפרעם |
Recent registry events
| Date | Event |
|---|---|
| 2026-03-23 | העברת מניות |
| 2026-03-23 | הקצאת מניות |
| 2026-03-18 | עדכון בעלי תפקידים |
| 2026-06-11 | עדכון כתובת ו/או מען דיגיטלי |
| 2026-04-09 | סילוק שעבוד |
| 2026-04-01 | סילוק שעבוד |
| 2026-04-01 | סילוק שעבוד |
| 2026-04-01 | רישום שעבוד |